Epstein-Barr virus infection in patients with MOGAD
Multiple Sclerosis Journal · 2025-01 · 31 (1) · 117-120
DOI: 10.1177/13524585241298065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Multiple Sclerosis Journal, online erschienen am 13.12.2024. Verfasst von Giorgia T Maniscalco und 14 weiteren Autor:innen. Beteiligte Einrichtung: Neurological Clinic and Stroke Unit, Multiple Sclerosis Regional Center, "A. Cardarelli" Hospital, Naples, Italy. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Myelin-Oligodendrocyte Glycoprotein, Epstein-Barr Virus Nuclear Antigens, Antibodies, Viral. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Background
Epstein-Barr virus (EBV) infection increases the risk of having multiple sclerosis (MS). Data on adults with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are lacking.
Objective
To compare EBV serological status in MOGAD versus MS.
Methods
We measured antibodies to Epstein-Barr nuclear antigen (EBNA-1) and viral capsid antigen (VCA) antigens in 129 patients (MS = 74, MOGAD = 55) by chemiluminescence immunoassays.
Results
VCA-IgG were detected in 97.3% of MS and 96.4% of MOGAD cases, while EBNA-1-IgG in 97.3% of MS and 80% of MOGAD ( p = 0.001). EBNA-1 ( p < 0.001) and VCA ( p = 0.03) antibodies levels were higher in MS patients.
Conclusion
EBV antibodies are higher in MS versus MOGAD, suggesting a possible different role of EBV in the pathogenesis of the two conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurological Clinic and Stroke Unit, Multiple Sclerosis Regional Center, "A. Cardarelli" Hospital, Naples, Italy.
- Multiple Sclerosis and Neuroimmunology Center, "A. Cardarelli" Hospital, Naples, Italy.
- Neurology Unit, Biomedicine, and Movement Sciences, University of Verona, Verona, Italy.
- Clinical Pathology and Microbiology Laboratory, "A. Cardarelli" Hospital, Naples, Italy.
- Department of Translational Medical Sciences, Section of Clinical Immunology, University of Naples Federico II, Naples, Italy.
- Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, University of Naples Federico II, Naples, Italy.
ORCID-Profile: Giorgia T Maniscalco
Zitieren
APA
Maniscalco, G. T., Dinoto, A., Foglia, M. C., Di Battista, M. E., Moreggia, O., Di Giulio Cesare, D., Williams, M., Rossi, F. W., Carta, S., Chiodega, V., Ferrari, S., Viola, A., de Paulis, A., Andreone, V., & Mariotto, S. (2025). Epstein-Barr virus infection in patients with MOGAD. Multiple Sclerosis Journal, 31(1), 117-120. https://doi.org/10.1177/13524585241298065
Vancouver
Maniscalco GT, Dinoto A, Foglia MC, Di Battista ME, Moreggia O, Di Giulio Cesare D, et al. Epstein-Barr virus infection in patients with MOGAD. Multiple Sclerosis Journal. 2025;31(1):117-120. doi:10.1177/13524585241298065
BibTeX
@article{Maniscalco2025,
author = {Maniscalco, Giorgia T and Dinoto, Alessandro and Foglia, Maria C and Di Battista, Maria E and Moreggia, Ornella and Di Giulio Cesare, Daniele and Williams, Michela and Rossi, Francesca W and Carta, Sara and Chiodega, Vanessa and Ferrari, Sergio and Viola, Assunta and de Paulis, Amato and Andreone, Vincenzo and Mariotto, Sara},
title = {Epstein-Barr virus infection in patients with MOGAD},
journal = {Multiple Sclerosis Journal},
year = {2025},
volume = {31},
number = {1},
pages = {117--120},
doi = {10.1177/13524585241298065}
}
EUVIMED